Aligos Therapeutics, Inc. (ALGS)
9.47
+0.35
(+3.84%)
USD |
NASDAQ |
Dec 31, 12:51
Aligos Therapeutics Market Cap: 58.27M for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| CEL-SCI Corp. | 16.27M |
| AIM ImmunoTech, Inc. | 0.8559M |
| IGC Pharma, Inc. | 26.00M |
| NovaBay Pharmaceuticals, Inc. | 688.02M |
| Protalix Biotherapeutics, Inc. | 143.15M |
Market Cap Related Metrics
| PS Ratio | 31.95 |
| PEG Ratio | -0.0100 |
| Price to Book Value | 0.8113 |
| Price | 9.47 |
| Earnings Yield | -208.7% |
| PEGY Ratio | -0.0100 |